SummaryBackgroundHeterozygous familial hypercholesterolaemia (HeFH) is a severe autosomal dominant disease that is underdiagnosed, inadequately treated and has a severe long-term cardiovascular risk. Few studies have evaluated the long-term risk of high low-density lipoprotein cholesterol (LDL-C) concentrations.AimTo evaluate long-term mortality in a large cohort of healthy subjects, according to LDL-C concentrations.MethodsBased on a sample of 6956 subjects visiting a preventive cardiology department, we selected adult subjects without a personal history of cardiovascular disease. From 1995 to 2011, 4930 healthy subjects were examined and followed up until 31 December 2011. All-cause deaths were collected exhaustively. A Cox-based multivar...
Abstract The association between low density lipoprotein cholesterol (LDL-C) and all-cause mortality...
Background: Dyslipidaemia, especially elevated low-density lipoprotein cholesterol (LDL-C), is on...
BackgroundHeterozygous Familial Hypercholesterolemia (HeFH) is a severe autosomal dominant disease w...
SummaryBackgroundHeterozygous familial hypercholesterolaemia (HeFH) is a severe autosomal dominant d...
AimWe sought to determine achievement of lipid targets according to current European guidelines (low...
BackgroundThe 2012 ESC guidelines recommend a LDL-cholesterol (LDL-C) lower than 3mmol/L for subject...
BackgroundCurrent guidelines recommend a low-density lipoprotein cholesterol (LDL-C) target of<1.8mm...
PurposeThe beneficial effect of lipid-lowering drugs on cardiovascular mortality is well established...
PurposeCurrent guidelines recommend lowering LDL-cholesterol below 2.6 mmol/L in patients with estab...
BACKGROUND: Benefits of elevated high-density lipoprotein cholesterol (HDL-C) levels are challenged ...
AimsAortic valve stenosis is commonly considered a degenerative disorder with no recommended prevent...
AimTo document low-density lipoprotein cholesterol (LDL-C) values during hospitalization of ACS pati...
SummaryBackgroundScreening for and management of dyslipidaemia are crucial in primary and secondary ...
ObjectivesThis study was designed to test the hypothesis that at any low-density lipoprotein cholest...
Background and aims Low-density lipoprotein (LDL)-cholesterol (LDL-C) promotes atherosclerotic card...
Abstract The association between low density lipoprotein cholesterol (LDL-C) and all-cause mortality...
Background: Dyslipidaemia, especially elevated low-density lipoprotein cholesterol (LDL-C), is on...
BackgroundHeterozygous Familial Hypercholesterolemia (HeFH) is a severe autosomal dominant disease w...
SummaryBackgroundHeterozygous familial hypercholesterolaemia (HeFH) is a severe autosomal dominant d...
AimWe sought to determine achievement of lipid targets according to current European guidelines (low...
BackgroundThe 2012 ESC guidelines recommend a LDL-cholesterol (LDL-C) lower than 3mmol/L for subject...
BackgroundCurrent guidelines recommend a low-density lipoprotein cholesterol (LDL-C) target of<1.8mm...
PurposeThe beneficial effect of lipid-lowering drugs on cardiovascular mortality is well established...
PurposeCurrent guidelines recommend lowering LDL-cholesterol below 2.6 mmol/L in patients with estab...
BACKGROUND: Benefits of elevated high-density lipoprotein cholesterol (HDL-C) levels are challenged ...
AimsAortic valve stenosis is commonly considered a degenerative disorder with no recommended prevent...
AimTo document low-density lipoprotein cholesterol (LDL-C) values during hospitalization of ACS pati...
SummaryBackgroundScreening for and management of dyslipidaemia are crucial in primary and secondary ...
ObjectivesThis study was designed to test the hypothesis that at any low-density lipoprotein cholest...
Background and aims Low-density lipoprotein (LDL)-cholesterol (LDL-C) promotes atherosclerotic card...
Abstract The association between low density lipoprotein cholesterol (LDL-C) and all-cause mortality...
Background: Dyslipidaemia, especially elevated low-density lipoprotein cholesterol (LDL-C), is on...
BackgroundHeterozygous Familial Hypercholesterolemia (HeFH) is a severe autosomal dominant disease w...